OpGen Inc (OPGN): OPGN and Lazar plays are lame. OTC sto...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	68
Posts	8379
Boards Moderated	0
Alias Born	10/02/2018

Laster

Re: reena969 post# 2717

Thursday, 03/28/2024 7:51:22 AM

Thursday, March 28, 2024 7:51:22 AM

OPGN and Lazar plays are lame.
OTC stocks aren’t fun when the current plays are low float Nasdaq stocks.
But… great calls on GCTS and IBIO.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent OPGN News

OpGen Provides Update on Business Operations and Strategic Opportunities • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K • GlobeNewswire Inc. • 04/23/2024 08:15:00 PM
Shares Rip In Reaction To Activist Investor Becoming CEO • AllPennyStocks.com • 03/26/2024 08:20:00 PM
OpGen Announces Acquisition of Preferred Stock by David Lazar • GlobeNewswire Inc. • 03/25/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 12:30:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:30:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:58:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:37:15 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/24/2023 05:15:18 AM
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 09:30:00 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2023 09:59:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:30:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 08:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 08:30:09 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:18:03 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/13/2023 09:17:02 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:15:31 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:14:21 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/13/2023 09:13:12 PM
OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds • GlobeNewswire Inc. • 10/12/2023 04:32:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:40:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:30:10 PM
Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 09/28/2023 08:24:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:30:09 PM

More OPGN News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover